Search

Displaying results 7331 - 7340 of 10000 in total
  1. Drug

    AAV9/MFSD8

    go.drugbank.com/drugs/DB18616
    Experimental

    AAV9/MFSD8 is a gene therapy developed by Neurogene Inc.

  2. Indication

    Congenital aplastic anaemia

    go.drugbank.com/conditions/DBCOND0007164
    Drugs: Oxymetholone
    Synonyms: Constitutional aplastic anemia, NOS, Constitutional aplastic anemia NOS (disorder)
  3. Indication

    Cystic Fibrosis (CF)

    go.drugbank.com/conditions/DBCOND0040212
    Drugs: Aztreonam · Beraprost · Cimetidine · Deutivacaftor · Dornase alfa · Elexacaftor +6 more
    Synonyms: Cystic fibrosis NOS, Cystic fibrosis NOS (disorder)
  4. Indication

    Fat malabsorption

    go.drugbank.com/conditions/DBCOND0020593
    Drugs: Pancrelipase
    Synonyms: Steatorrhea, NOS, Steatorrhoea, NOS
  5. Indication

    Myoclonic seizures

    go.drugbank.com/conditions/DBCOND0022716
    Drugs: Clonazepam · Levetiracetam · Nitrazepam
    Synonyms: Myoclonic seizure NOS, (Myoclonus NOS) or (Unverricht-Lundborg disease) or (myoclonic seizure)
  6. Drug

    CX501

    go.drugbank.com/drugs/DB05174
    Investigational

    It is developed by Cellerix and is in phase I of clinical trials.

  7. Drug

    BGB-DXP593

    go.drugbank.com/drugs/DB16357
    Investigational

    the clinical trial NCT04551898 (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)) by

  8. Drug

    Devafidugene civaparvovec

    go.drugbank.com/drugs/DB16790
    Investigational

    Developed by Sangamo Therapeutics, Inc., devafidugene civaparvovec is being investigated for the treatment of mucopolysaccharidosis Type I (MPS I).[L46716]

  9. Drug

    SCIB1

    go.drugbank.com/drugs/DB18439
    Investigational

    SCIB1 is an investigational cancer vaccine being developed by Scancell Ltd. It is being investigated for the treatment of melanoma.

  10. Drug

    NGN-401

    go.drugbank.com/drugs/DB18594
    Investigational

    Developed by Neurogene Inc., it is being investigated for the treatment of Rett syndrome.